The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice

In conclusion, nitazoxanide inhibits liver fibrosis and the underlying mechanisms involve AMPK activation, and STAT3 and Smad2/3 inhibition.PMID:38615918 | DOI:10.1016/j.bcp.2024.116205

Source: Biochemical Pharmacology - April 14, 2024 Category: Drugs & Pharmacology Authors: Kai-Xin Liu Zeng-Yang Wang Ya-Ting Ying Rui-Miao Wei De-Li Dong Zhi-Jie Sun Source Type: research